• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎表面抗原通过诱导肝癌细胞中的细胞 microRNA 抑制 MICA 和 MICB 的表达。

Hepatitis B surface antigen inhibits MICA and MICB expression via induction of cellular miRNAs in hepatocellular carcinoma cells.

机构信息

Institute of Genomic Medicine, Wenzhou Medical College, 268 Xueyuan Road, Wenzhou, Zhejiang Province 325000, P.R. China.

出版信息

Carcinogenesis. 2014 Jan;35(1):155-63. doi: 10.1093/carcin/bgt268. Epub 2013 Aug 5.

DOI:10.1093/carcin/bgt268
PMID:23917076
Abstract

Hepatitis B surface antigen (HBsAg) seropositivity is an important risk factor for hepatocellular carcinoma (HCC), and HBsAg-transgenic mice have been reported to spontaneously develop HCC. The major histocompatibility complex class I-related molecules A and B (MICA and MICB) are NKG2D ligands that play important roles in tumor immune surveillance. In the present study, we found that HBsAg overexpression in HepG2 cells led to upregulation of 133 and downregulation of 9 microRNAs (miRNAs). Interestingly, several HBsAg-induced miRNAs repressed the expression of MICA and MICB via targeting their 3'-untranslated regions. In addition, the expression of MICA and MICB was significantly reduced upon HBsAg overexpression, which was partially restored by inhibiting the activities of HBsAg-induced miRNAs. Moreover, HBsAg-overexpressing HCC cells exhibited reduced sensitivity to natural killer cell-mediated cytolysis. Taken together, our data suggest that HBsAg supresses the expression of MICA and MICB via induction of cellular miRNAs, thereby preventing NKG2D-mediated elimination of HCC cells.

摘要

乙型肝炎表面抗原(HBsAg)阳性是肝细胞癌(HCC)的重要危险因素,已有报道称 HBsAg 转基因小鼠会自发发生 HCC。主要组织相容性复合体 I 类相关分子 A 和 B(MICA 和 MICB)是 NKG2D 的配体,在肿瘤免疫监视中发挥重要作用。在本研究中,我们发现 HepG2 细胞中 HBsAg 的过表达导致 133 个 miRNA 的上调和 9 个 miRNA 的下调。有趣的是,一些 HBsAg 诱导的 miRNA 通过靶向它们的 3'-UTR 抑制 MICA 和 MICB 的表达。此外,HBsAg 过表达后 MICA 和 MICB 的表达显著降低,通过抑制 HBsAg 诱导的 miRNA 的活性部分恢复。此外,HBsAg 过表达的 HCC 细胞对自然杀伤细胞介导的细胞溶解的敏感性降低。总之,我们的数据表明,HBsAg 通过诱导细胞 miRNA 抑制 MICA 和 MICB 的表达,从而防止 NKG2D 介导的 HCC 细胞消除。

相似文献

1
Hepatitis B surface antigen inhibits MICA and MICB expression via induction of cellular miRNAs in hepatocellular carcinoma cells.乙型肝炎表面抗原通过诱导肝癌细胞中的细胞 microRNA 抑制 MICA 和 MICB 的表达。
Carcinogenesis. 2014 Jan;35(1):155-63. doi: 10.1093/carcin/bgt268. Epub 2013 Aug 5.
2
Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth.基于慢病毒 microRNA 的系统敲低 HBV 表面抗原基因表达抑制 HBV 复制和 HCC 生长。
J Viral Hepat. 2011 Sep;18(9):653-60. doi: 10.1111/j.1365-2893.2010.01346.x. Epub 2010 Jul 19.
3
Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid.MICA和MICB在人类肝细胞癌中的表达、作用及其受视黄酸的调控
Int J Cancer. 2003 Apr 10;104(3):354-61. doi: 10.1002/ijc.10966.
4
MicroRNA-581 promotes hepatitis B virus surface antigen expression by targeting Dicer and EDEM1.微小 RNA-581 通过靶向 Dicer 和 EDEM1 促进乙型肝炎病毒表面抗原的表达。
Carcinogenesis. 2014 Sep;35(9):2127-33. doi: 10.1093/carcin/bgu128. Epub 2014 Jun 9.
5
Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.组蛋白去乙酰化酶抑制剂丙戊酸钠通过特异性诱导NKG2D配体介导自然杀伤细胞对肝癌细胞的杀伤作用。
Cancer Res. 2005 Jul 15;65(14):6321-9. doi: 10.1158/0008-5472.CAN-04-4252.
6
HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines.HER2/HER3 信号通过人乳腺癌细胞系中 MHC Ⅰ类链相关分子 A 和 B 的表达调节 NK 细胞介导的细胞毒性。
J Immunol. 2012 Mar 1;188(5):2136-45. doi: 10.4049/jimmunol.1102237. Epub 2012 Feb 1.
7
MicroRNA-34a promotes MICB expression in hepatocytes.MicroRNA-34a 促进肝细胞中 MICB 的表达。
Carcinogenesis. 2018 Dec 31;39(12):1477-1487. doi: 10.1093/carcin/bgy128.
8
miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3.miR-122 抑制乙型肝炎病毒相关肝细胞癌中的病毒复制和细胞增殖,并靶向 NDRG3。
Oncol Rep. 2011 Nov;26(5):1281-6. doi: 10.3892/or.2011.1375. Epub 2011 Jul 1.
9
Separate origins of hepatitis B virus surface antigen-negative foci and hepatocellular carcinomas in transgenic HBsAg (alb/psx) mice.转基因 HBsAg(alb/psx)小鼠中乙型肝炎病毒表面抗原阴性病灶与肝细胞癌的不同起源
Am J Pathol. 2006 Jul;169(1):223-32. doi: 10.2353/ajpath.2006.051284.
10
Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.颗粒蛋白前体使肝癌细胞对自然杀伤细胞的细胞毒性具有抗性。
Cancer Immunol Res. 2014 Dec;2(12):1209-19. doi: 10.1158/2326-6066.CIR-14-0096. Epub 2014 Oct 14.

引用本文的文献

1
Resveratrol contributes to NK cell-mediated breast cancer cytotoxicity by upregulating ULBP2 through miR-17-5p downmodulation and activation of MINK1/JNK/c-Jun signaling.白藜芦醇通过下调miR-17-5p和激活MINK1/JNK/c-Jun信号通路来上调ULBP2,从而促进自然杀伤细胞介导的乳腺癌细胞毒性作用。
Front Immunol. 2025 Feb 3;16:1515605. doi: 10.3389/fimmu.2025.1515605. eCollection 2025.
2
Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses.沙贝病毒逃避 NKG2D 介导的细胞毒性免疫。
Cell. 2024 May 9;187(10):2393-2410.e14. doi: 10.1016/j.cell.2024.03.026. Epub 2024 Apr 22.
3
Impact of MICA 3'UTR allelic variability on miRNA binding prediction, a bioinformatic approach.
MICA 3'非翻译区等位基因变异性对miRNA结合预测的影响:一种生物信息学方法
Front Genet. 2023 Dec 7;14:1273296. doi: 10.3389/fgene.2023.1273296. eCollection 2023.
4
Current tests for diagnosis of hepatitis B virus infection and immune responses of HBV-related HCC.目前用于诊断乙型肝炎病毒感染及HBV相关肝癌免疫反应的检测方法。
Front Oncol. 2023 Nov 28;13:1185142. doi: 10.3389/fonc.2023.1185142. eCollection 2023.
5
A signature based on NKG2D ligands to predict the recurrence of hepatocellular carcinoma after radical resection.基于 NKG2D 配体的signature 预测肝癌根治性切除术后的复发。
Cancer Med. 2023 Mar;12(5):6337-6347. doi: 10.1002/cam4.5318. Epub 2022 Oct 9.
6
Hepatitis B Virus-Encoded HBsAg Contributes to Hepatocarcinogenesis by Inducing the Oncogenic Long Noncoding RNA LINC00665 through the NF-κB Pathway.乙型肝炎病毒编码的 HBsAg 通过 NF-κB 通路诱导致癌长非编码 RNA LINC00665 促进肝癌发生。
Microbiol Spectr. 2022 Oct 26;10(5):e0273121. doi: 10.1128/spectrum.02731-21. Epub 2022 Aug 22.
7
Occult hepatitis B - the result of the host immune response interaction with different genomic expressions of the virus.隐匿性乙型肝炎——宿主免疫反应与病毒不同基因组表达相互作用的结果。
World J Clin Cases. 2022 Jun 16;10(17):5518-5530. doi: 10.12998/wjcc.v10.i17.5518.
8
Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection.适应性免疫应答、免疫逃避和 HDV 感染期间的免疫介导发病机制。
Viruses. 2022 Jan 20;14(2):198. doi: 10.3390/v14020198.
9
HBsAg Dampened STING Associated Activation of NK Cells in HBeAg-Negative CHB Patients.HBsAg 抑制 HBeAg 阴性 CHB 患者中 STING 相关的 NK 细胞激活。
Int J Mol Sci. 2021 Jul 16;22(14):7643. doi: 10.3390/ijms22147643.
10
The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways.HBV 相关肝细胞癌(HBV-HCC)和免疫途径中乙型肝炎病毒 X 蛋白(HBx)失调 microRNA 的多种作用。
Viruses. 2020 Jul 10;12(7):746. doi: 10.3390/v12070746.